Physician profile
Chadward L Thacker
NPI 1801811542
$1,147.18
in general payments reported to CMS, 2019-2025
18 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $129 · 2021: $254 · 2022: $156 · 2023: $66.30 · 2024: $76.27 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $270.89 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $258.69 | 2019-2022 | |
| Pfizer INC. | $139.23 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $70.55 | 2019-2022 | |
| Amarin Pharma, INC. | $49.08 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $42.91 | 2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $40.95 | 2020-2024 | Trintellix |
| Janssen Pharmaceuticals, INC | $39.25 | 2019 | |
| Astellas Pharma US INC | $34.01 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.80 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.92 | 2019 | |
| Lilly USA, LLC | $29.51 | 2022-2023 | Jardiance, Emgality |
| Dexcom, INC. | $27.09 | 2025 | Dexcom G6 Transmitter |
| Allergan, INC. | $22.85 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.70 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.47 | 2025 | Wegovy |
| Biohaven Pharmaceuticals, INC. | $12.65 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chadward Thacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.